Article
Interferon-based Simeprevir Therapy for Pediatric Patients with Chronic Hepatitis C Viral Infection.
Annals of hepatology - 24 Aug 2018
Suzuki Mitsuyoshi, Minowa Kei, Tajiri Hitoshi
Abstract excerpt
Interferon-based simeprevir therapy showed high efficacy and tolerability in children with genotype 1 hepatitis C virus infection. While direct-acting antivirals (DAAs) therapy are undergoing study in children, this regimen is considered an available therapeutic option for selected patients in countries where DAAs have not yet been approved.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
